Navigation Links
Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
Date:9/9/2008

SAN FRANCISCO, Sept. 9 /PRNewswire/ -- Epiphany Biosciences, Inc. today announced that a Phase 2b dose-ranging study to evaluate the safety, efficacy, and tolerability of the company's lead compound, valomaciclovir (EPB-348) in patients with acute herpes zoster infection (shingles), will continue as originally designed following an interim analysis.

Fred Volinsky, MD, Epiphany's CEO said, "We are pleased with the progress of this clinical trial and look forward to the final data. If successful, valomaciclovir will mark an advance in the treatment of herpes zoster which affects more than two million people annually around the globe. As the world population ages, it is expected that the incidence of this disease will grow significantly, especially in lieu of the lackluster response to vaccines in this area. We look to valomaciclovir to enhance the treatment experience by being the first once-daily therapy for shingles." The Phase 2b study is being conducted at sites throughout North America and uses an active comparator, valacyclovir. Outcomes assessed include various efficacy parameters including time to vesicular resolution and safety data collection.

In addition to the Phase 2b zoster study, valomaciclovir will also be studied in a separate Phase 2 clinical trial as a therapy in managing the most severe sequelae of a herpes-zoster infection, post-herpetic neuralgia or PHN. "The spectrum of disease caused by herpes viruses is underappreciated but a disease like shingles can have a profound impact on the quality-of-life of patients, many times leading to severe pain syndromes that could have a viral etiology. We look forward to examining the clinical utility of valomaciclovir in multiple conditions associated with herpes viruses and plan to maximize the broad-acting antiviral profile of this drug," reported Brian Murphy, MD, Chief Medical Officer of Epiphany.

In addition to the studies directed at herpes zoster, valomaciclovir is also bein
'/>"/>

SOURCE Epiphany Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
2. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
3. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
7. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
8. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
9. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
10. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Decision Resources Group finds that ... Memphis health system and hospital sector ... with rivals Methodist Le Bonheur Healthcare and Baptist Memorial ... coordinate patient care. In addition, a national contract recently ... health plan enrollment in the Memphis ...
(Date:8/27/2014)... ALBANY, New York , August 27, 2014 /PRNewswire/ ... on United States  Laparoscopes Market Outlook ... to 2020", provides key market data on the ... in millions of US dollars, volume (in units) and ... Laparoscopes (Rigid Tip Video Laparoscopes and Flexible Tip Video ...
(Date:8/27/2014)... 27, 2014 An experimental drug designed to help ... first treatment for anemia of inflammation, according to results from ... online today in Blood , the Journal ... Anemia is a condition that occurs when red ... properly. When an individual has anemia, the body does not ...
Breaking Medicine Technology:Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3
... & Melinda Gates Foundation today announced that Dr. Trevor Mundel ... Mundel, who is currently global head of development for Novartis ... work at the foundation on December 1. "We ... our global health program," said Bill Gates, co-chair of the ...
... Inc. is pleased to announce its exclusive agreement with ... automated FIT product, a fecal occult blood analyzer that ... the early detection of colorectal cancer. The agreement includes ... and OC-Sensor Diana, a high throughput automated FIT analyzer, ...
Cached Medicine Technology:Gates Foundation Names Dr. Trevor Mundel to Lead Global Health Program 2Polymedco, Inc., and Cardinal Health Sign Agreement for Distribution of Oncologic Diagnostic Test Kits to Acute Care Market 2
(Date:8/27/2014)... of the last things a parent wants to deal ... less than a week old. , Skin that turns ... is jaundiced and isn,t adequately eliminating the chemical bilirubin. ... severe jaundice left untreated can harm a baby. , ... smartphone application that checks for jaundice in newborns and ...
(Date:8/27/2014)... symptoms, did you look for advice online before ... alone. Consumers are increasingly turning to forums, video-sharing ... information and advice, which may distract them from ... be presented at the HFES 2014 Annual Meeting ... use the Internet to collect health-care information. ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 For nearly ... performances by the beloved mantra singers Deva Premal & ... Following the release of their latest album in May, ... down in twenty-two countries around the globe, including Russia, ... Argentina and across Europe. With a new album and ...
(Date:8/27/2014)... BESLER Consulting , a leading ... hospitals, is pleased to announce that it has been ... Fastest-Growing Companies. The list represents the most comprehensive look ... , "It's been an exciting year for our ... this year's Inc. 5000 list,” said Jonathan Besler, BESLER’s ...
(Date:8/27/2014)... 27, 2014 Home Care Assistance ... for seniors, is proud to announce the next installment ... webinar will feature Dr. Suzanne Steinbaum, attending cardiologist and ... in New York City, National Spokesperson for the American ... will cover the issues surrounding women and heart disease, ...
Breaking Medicine News(10 mins):Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3Health News:Educated consumers more likely to use potentially unreliable online healthcare information 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3
... WASHINGTON, Oct. 21 A report,( http://www.firstfocus.net/pages/3519/ ... in the health care plans of the presidential,candidates, ... identifies,both opportunities and concerns with the policy changes ... whether the plans would ensure,access to comprehensive and ...
... today a new agreement with Sun Healthcare Group to offer public ... Healthcare Corporation, collectively operate 208 skilled nursing, long-term care and assisted ... operating beds as of June 2008. , ... ...
... Oct. 21 In a ceremony today at,the Air ... Health with a model of an S-76(R) helicopter in,recognition ... helicopters. Sikorsky is a subsidiary of United Technologies Corp.,(NYSE: ... its new S-76C++(TM) helicopter earlier,this year and is exhibiting ...
... addicted to ... opioid painkillers and heroin., FARMINGTON, Conn., Oct. 21 Launched ... has connected nearly 14,000 addicted patients with physicians,certified to prescribe Suboxone ... allowed by law to prescribe this,treatment, and those that do have ...
... School Vikings score the title of Body By Milk ... and staying fit has,become second nature to the superstar ... "got milk?(R)" campaign announced today that the,Tigers Varsity football ... MVP,(Milk,s Valued Players). The team was nominated to be ...
... 21 Isolagen(TM), Inc. (Amex:,ILE) announced today that ... Study IT-A-008 investigating Isolagen Therapy(TM) for the treatment,of ... half of all,of the study participants have completed ... will conclude in the first quarter of,2009., ...
Cached Medicine News:Health News:New Report Analyzes How Children Fare in Candidates' Health Care Plans 2Health News:New Report Analyzes How Children Fare in Candidates' Health Care Plans 3Health News: Wayport Signs Agreement with Sun Healthcare Group to Enable Public Internet Access : Sun's Inpatient Services Subsidiaries to Utilize Public Applications Managed by Wayport 2Health News:Sikorsky Aircraft Recognizes Aero Med Spectrum Health Hospitals 2Health News:NAABT Patient/Physician Matching System A Success 2Health News:NAABT Patient/Physician Matching System A Success 3Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 2Health News:North Carolina School Wins National got milk?(R) Refuel Your School Contest 3Health News:Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study 2Health News:Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase II/III Acne Scar Study 3
Straight Shafts with Serrated 5mm Platform with 0.2 tips; overall length 105mm In Titanium...
Straight Shafts with 0.12mm 1X2 Teeth With 5mm Tying Platform; In Titanium...
45 Degree Angle With 0.3, 12 Teeth with 5mm Tying Platform; In Titanium....
0.3mm tips; 9.5mm from tips to cross action; in Titanium....
Medicine Products: